Tag: Mydecine - Psilocybin Alpha

New Resource: Psychedelics Drug Development Tracker

Mydecine Announces Partnership with LeadGen Labs

Mydecine Announces Partnership with LeadGen Labs

Post published:May 5, 2021
Post category:Press Release

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Mydecine Reports Full Year 2020 Financial Results and Provides Business Update

Post published:May 3, 2021
Post category:Press Release

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Mydecine to Report Full Year 2020 Financial Results on May 3, 2021

Post published:April 26, 2021
Post category:Press Release

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Mydecine Announces Launch of Cutting-Edge Therapeutic Compound Screening

Post published:April 13, 2021
Post category:Press Release

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical

Post published:April 7, 2021
Post category:Press Release

Mydecine Innovations Group Announces Migration to NEO Exchange

Mydecine Innovations Group Announces Migration to NEO Exchange

Post published:March 23, 2021
Post category:Press Release

Mydecine Innovations Group Provides Update on European Operations

Mydecine Innovations Group Provides Update on European Operations

Post published:March 16, 2021
Post category:Press Release

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

Post published:March 10, 2021
Post category:Press Release

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Post published:March 1, 2021
Post category:Press Release

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Mydecine Announces Exclusive Partnership and Increased Capabilities with Applied Pharmaceutical Innovation (API) at the University of Alberta

Post published:February 24, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.